Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00413374 · ClinicalTrials.gov registry record · NA
Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
A NA study of Pulmonary Embolism and Deep Vein Thrombosis, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00413374: Completed NA study of Pulmonary Embolism and Deep Vein Thrombosis, sponsored by Brigham and Women's Hospital.
NCT00413374 is a NA study of Pulmonary Embolism and Deep Vein Thrombosis that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants, below the 3,058-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00413374, a NA study of Pulmonary Embolism and Deep Vein Thrombosis, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To investigate the efficacy and safety of once daily enoxaparin as a "bridge" to warfarin for the outpatient treatment of acute deep venous thrombosis or pulmonary embolism.
Primary Outcome
Major bleeding complication as defined as spinal, retroperitoneal, or intracranial bleeding; drop in hemoglobin ≥2g/dl or transfusion ≥2U or surgical or medical intervention, death related to bleeding.
Conditions Studied
Interventions
- DRUG Enoxaparin
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-05 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT00413374 record still lists
NCT00413374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,058-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Enoxaparin is the first listed.
NCT00413374 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00413374 about?
NCT00413374 is a clinical study titled "Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism". To investigate the efficacy and safety of once daily enoxaparin as a "bridge" to warfarin for the outpatient treatment of acute deep venous thrombosis or pulmonary embolism.
What is the current status of trial NCT00413374?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2006-05. Estimated completion is 2008-12.
What conditions does trial NCT00413374 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Deep Vein Thrombosis.
What interventions are being tested in trial NCT00413374?
The interventions under investigation include: Enoxaparin (DRUG).
Who is sponsoring clinical trial NCT00413374?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00413374 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00413374's enrollment target sits among peer trials
40 42nd of 48 higher than 7 of 48 other Pulmonary Embolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
The PEERLESS II Study
RECRUITING · NA
-
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia